Stephen P. Arneric, PhD

Steve joined the Critical Path Institute in 2015 and leads the Coalition Against Major Diseases (CAMD) to build drug development tools with industry (14 members), academic, and key patient advocacy foundations (5 members), and qualify these tools with regulators such as the FDA & EMA to accelerate the delivery of foundational information required to deliver innovative medicines to treat Alzheimer’s disease and related neurodegenerative disorders with impaired cognition and function.

Prior to joining the Critical Path Institute, Steve was an accomplished pharmaceutical scientist and leader with a proven track record to deliver differentiated therapeutics. Experience spanning more than 25 years of large pharma (Abbott, Lilly, Pharmacia, & Pfizer), biotechnology (DuPont Pharmaceuticals, Neuromed Pharmaceuticals), and academic service (University of Iowa, Cornell Medical College, Southern Illinois University School of Medicine) resulted in 30+ drug candidates entering into clinical development to treat pain, neurological, psychiatric, and urological diseases. Dr. Arnerić has demonstrated his ability to lead complex cross-functional matrix organizations of 100+ staff, and effectively manage budgets within target. His Ph3 or Launched Product Development experience includes the following: Exalgo™(Oros-hydromorphone for OA & CLBP), Esreboxetine (DPNP), Dynastat™(acute pain), Lyrica™(neuropathic pain), Cymbalta™ (musculoskeletal pain, fibromyalgia, DPNP), Mirapex™(Parkinson’s Disease, RLS) and Detrol™(overactive bladder). He is a leader that leverages global alliances and cross-organizational strengths to maximize organizational efficiencies (Merck, Recordati, Covance, NeuroSearch, RaQualia, Jubilant, Noxxon, Arteus, PsychoGenics, AnaBios, Chorus, Scripps, Univ of Pittsburgh, University of Colorado, University of Geneva, ORCATECH, Univ. of Arizona, Univ. of British Columbia, etc.). Dr. Arnerić is a medical educator experienced in teaching medical students, graduate students, and neuroscience medical liaisons – he currently holds a position as Adjunct Professor of Pharmacology, SIU School of Medicine, and Research Professor of Medicine, The University of Arizona. He has authored 146 peer-reviewed articles, 201 abstracts, 17 chapters, 1 book, numerous IND submissions, as well as being a co-inventor/author of 15 patents.